FEI Announces Detection Times for Meloxicam

The FEI has announced detection times for Meloxicam (veterinary formulation known as Metacam®), a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain and inflammation in the equine athlete.

The findings of studies on the use of intravenously or orally administered Meloxicam show the urine and plasma (blood) detection time as 72 hours1.

This is the first COX-2 inhibitor on the FEI List of Detection Times, which contains common medications administered out of competition and is listed on the FEI Clean Sport website.

“We are committed to providing the tools to assist our athletes to adhere to the FEI’s Equine Anti-Doping Rules, and will add further medication detection times over the coming 12 months,” explains Graeme Cooke, Director of Veterinary Department at the FEI.

Meloxicam (Metacam®) is developed by Boehringer-Ingelheim

More from Horse Sport:

Christilot Boylen Retires From Team Sport

After an exemplary career as one of Canada’s top Dressage riders, seven-time Olympian Christilot Boylen has announced her retirement from team competition.

2020 Royal Agricultural Winter Fair Cancelled

For only the second time in its history, The Royal Agricultural Winter Fair has been cancelled but plans are being made for some virtual competitions.

Royal Agricultural Winter Fair Statement on 2020 Event

As the Province of Ontario starts to reopen, The Royal’s Board and staff will adhere to all recommendations put forward by government and health officials.

Government Financial Assistance for Ontario Farmers

Ontario Equestrian has recently released this update of several financial assistance packages available, including those for farm business.